参考文献/References:
[1]Zhang Y,Zhao L,Yang S,et al.CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression[J].J Exp Clin Cancer Res,2020,39(1):281.[2]Wen JF,Jiang YQ,Li C,et al.LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2[J].Cancer Biomark,2020,28(2):231-246.[3]Chen J,Yu Y,Li H,et al.Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer[J].Mol Cancer,2019,18(1):33.[4]Gao Y,Wang Z,Tong J,et al.LncRNA loc285194 inhibits tumor growth of laryngeal squamous cell carcinoma cells by downregulating hexokinase 2[J].Exp Ther Med,2019,18(4):2378-2384.[5]Gao SJ,Ren SN,Liu YT,et al.Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis[J].Mol Ther Oncolytics,2021,23:14-25.[6]Chen J,Yu Y,Li H,et al.Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer[J].Mol Cancer,2019,18(1):33.[7]Zhang X,Cui Y,Ding X,et al.Analysis of mRNA lncRNA and mRNA lncRNA-pathway co expression networks based on WGCNA in developing pediatric sepsis[J].Bioengineered,2021,12(1):1457-1470.[8]Song H,Li D,Wang X,et al.HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression[J].J Hematol Oncol,2020,13(1):24.[9]Zhang J,Chen G,Gao Y,et al.HOTAIR/miR-125 axis-mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma[J].J Cell Mol Med,2020,24(10):5707-5717.[10]Fan JL,Zhu TT,Xue ZY,et al.lncRNA-XIST protects the hypoxia-induced cardiomyocyte injury through regulating the miR-125b-hexokianse 2 axis[J].In Vitro Cell Dev Biol Anim,2020,56(4):349-357.[11]Zhang Y,Liu Y,Xu X.Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway[J].J Cell Biochem,2018,119(7):6296-6308.[12]Chen C,Wei M,Wang C,et al.Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2[J].Aging (Albany NY),2020,12(12):11685-11697. [13]Wang L,Huang Q,Lin Q,et al.Knockdown of long non-coding RNA small nucleolar RNA host gene 9 or hexokinase 2 both suppress endometrial cancer cell proliferation and glycolysis[J].J Obstet Gynaecol Res,2021,47(6):2196-2203.[14]Yu P,Wilhelm K,Dubrac A,et al.FGF-dependent metabolic control of vascular development[J].Nature,2017,545:224-228.[15]Yin X,Choudhury M,Kang JH,et al.Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-beta[J].Signal,2019,12:eaax4067. [16]Podar K,Anderson KC.A therapeutic role for targeting c-akt/Hif-1-dependent signaling pathways[J].Cell Cycle,2010,9:1722-1728.[17]Corona JC,Gimenez-Cassina A,Lim F,et al.Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson’s disease[J].J Neurosci Res,2010,88:1943-1950.[18]Li C,Wang P,Du J,et al.LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer[J].IUBMB Life,2021,73(1):286-298.
相似文献/References:
[1]侯梦月,黄金智,张玲莉.SIRT2及其与子宫内膜癌关系的研究进展[J].医学信息,2019,32(05):31.[doi:10.3969/j.issn.1006-1959.2019.05.012]
HOU Meng-yue,HUANG Jin-zhi,ZHANG Ling-li.Progress in the Study of SIRT2 and its Relationship with Endometrial Cancer[J].Journal of Medical Information,2019,32(19):31.[doi:10.3969/j.issn.1006-1959.2019.05.012]
[2]崔方强.足细胞上皮间质转分化研究[J].医学信息,2019,32(22):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
CUI Fang-qiang.Epithelial Transdifferentiation of Podocytes[J].Journal of Medical Information,2019,32(19):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
[3]张伟斌,荆国杰.胶质母细胞瘤信号通路的研究[J].医学信息,2019,32(23):33.[doi:10.3969/j.issn.1006-1959.2019.23.009]
ZHANG Wei-bin,JING Guo-jie.Study on Glioblastoma Signaling Pathway[J].Journal of Medical Information,2019,32(19):33.[doi:10.3969/j.issn.1006-1959.2019.23.009]
[4]王东梅,张展英.小细胞肺癌中信号通路及蛋白相互作用网络分析[J].医学信息,2020,33(01):81.[doi:10.3969/j.issn.1006-1959.2020.01.025]
WANG Dong-mei,ZHANG Zhan-ying.Analysis of Signal Pathways and Protein Interaction Networks in Small Cell Lung Cancer[J].Journal of Medical Information,2020,33(19):81.[doi:10.3969/j.issn.1006-1959.2020.01.025]
[5]焦 乐.PEBP4蛋白在复发性脑胶质瘤患者中的表达情况及临床意义分析[J].医学信息,2020,33(08):131.[doi:10.3969/j.issn.1006-1959.2020.08.042]
JIAO Le.Expression and Clinical Significance of PEBP4 Protein in Patients with Recurrent Glioma[J].Journal of Medical Information,2020,33(19):131.[doi:10.3969/j.issn.1006-1959.2020.08.042]
[6]朱明明,李占全,崔 森.MMP-9信号通路调控乳腺癌发展的机制[J].医学信息,2020,33(13):22.[doi:10.3969/j.issn.1006-1959.2020.13.007]
ZHU Ming-ming,LI Zhan-quan,CUI Sen.Mechanism of MMP-9 Signaling Pathway Regulating Breast Cancer Development[J].Journal of Medical Information,2020,33(19):22.[doi:10.3969/j.issn.1006-1959.2020.13.007]
[7]廖 伟,蔡崇明,陈金明,等.miR-200b-Notch信号通路对诱导性多能干细胞向神经干细胞分化的调控作用[J].医学信息,2020,33(16):65.[doi:10.3969/j.issn.1006-1959.2020.16.020]
LIAO Wei,CAI Chong-ming,CHEN Jin-ming,et al.Regulation of miR-200b-Notch Signaling Pathway on the Differentiation of Induced Pluripotent Stem Cells into Neural Stem Cells[J].Journal of Medical Information,2020,33(19):65.[doi:10.3969/j.issn.1006-1959.2020.16.020]
[8]文先丽,施会敏,张爱青.长链非编码RNA相关信号通路参与肾脏纤维化的研究[J].医学信息,2020,33(21):26.[doi:10.3969/j.issn.1006-1959.2020.21.009]
WEN Xian-li,SHI Hui-min,ZHANG Ai-qing.Involvement of Long-chain Non-coding RNA Related Signaling Pathways in Renal Fibrosis[J].Journal of Medical Information,2020,33(19):26.[doi:10.3969/j.issn.1006-1959.2020.21.009]
[9]阳华妹.程序性死亡通路在胆红素脑病机制中的研究[J].医学信息,2021,34(10):43.[doi:10.3969/j.issn.1006-1959.2021.10.012]
YANG Hua-mei.The Study of Programmed Death Pathway in the Mechanism of Bilirubin Encephalopathy[J].Journal of Medical Information,2021,34(19):43.[doi:10.3969/j.issn.1006-1959.2021.10.012]
[10]吴亚娟,赵 楠,钱科佳,等.基于网络生物信息学筛选精神分裂症关键基因[J].医学信息,2021,34(16):1.[doi:10.3969/j.issn.1006-1959.2021.16.001]
WU Ya-juan,ZHAO Nan,QIAN Ke-jia,et al.Screening Key Genes of Schizophrenia Based on Network Bioinformatics[J].Journal of Medical Information,2021,34(19):1.[doi:10.3969/j.issn.1006-1959.2021.16.001]